FARNUM RHONDA (SVP, Comm & Medical Affairs) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/24/2026ACC: 0001898490-26-000012
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-5.67K
Net shares
Net seller
$96.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.67K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−5.67K
Price / share
$16.95
Trade value
$96.06K
% of position
2.4%
8/20/2026
232.46K→226.79K
Total
Net shares
−5.67K
Net value
-$96.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2026 | F · Tax Withholding | −5.67K | $16.95 | $96.06K | 2.4% | 232.46K | 226.79K |
| Total | −5.67K | -$96.06K | ||||||
Derivative Transactions0
No derivative transactions reported